OSRx, Inc. is a biopharma company that operates a 503B outsourcing facility, which makes and supplies sterile drugs for hospitals and clinics. It lobbied Congress on policies affecting 503B outsourcing facilities under the Drug Quality and Security Act (Public Law 113-54).
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ADAM HIGGINS
The latest disclosures for this client.
BAKER & HOSTETLER LLP
Q2BAKER & HOSTETLER LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
BAKER & HOSTETLER LLP
CHRIS JONES
BAKER & HOSTETLER LLP
PETER ROSKAM
BAKER & HOSTETLER LLP
BAKER & HOSTETLER LLP
Q4BAKER & HOSTETLER LLP
RR